150 related articles for article (PubMed ID: 19616063)
1. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
Hasanein P
Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
[TBL] [Abstract][Full Text] [Related]
2. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
Hasanein P; Javanmardi K
Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724
[TBL] [Abstract][Full Text] [Related]
3. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
4. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
6. Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: interaction between opioid and cannabinoid systems.
Shafaroodi H; Ghasemi M; Dehpour AR
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e251-7. PubMed ID: 17764531
[TBL] [Abstract][Full Text] [Related]
7. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
10. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
Hasanein P
J Psychopharmacol; 2011 Feb; 25(2):281-8. PubMed ID: 19825905
[TBL] [Abstract][Full Text] [Related]
11. Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
Mannucci C; Navarra M; Pieratti A; Russo GA; Caputi AP; Calapai G
Nicotine Tob Res; 2011 Apr; 13(4):239-47. PubMed ID: 21324836
[TBL] [Abstract][Full Text] [Related]
12. Histamine H(3) receptor modulates nociception in a rat model of cholestasis.
Hasanein P
Pharmacol Biochem Behav; 2010 Sep; 96(3):312-6. PubMed ID: 20576511
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Haranishi Y; Hara K; Terada T
Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
[TBL] [Abstract][Full Text] [Related]
14. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.
Scott DA; Wright CE; Angus JA
Pain; 2004 May; 109(1-2):124-31. PubMed ID: 15082134
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats.
Roche M; Kelly JP; O'Driscoll M; Finn DP
Immunology; 2008 Oct; 125(2):263-71. PubMed ID: 18393970
[TBL] [Abstract][Full Text] [Related]
16. Role of GABAA receptor in modulation of acute thermal pain using a rat model of cholestasis.
Hasanein P; Parviz M
Pharmacol Biochem Behav; 2014 Sep; 124():226-30. PubMed ID: 24955862
[TBL] [Abstract][Full Text] [Related]
17. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
18. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404.
Hájos N; Kathuria S; Dinh T; Piomelli D; Freund TF
Eur J Neurosci; 2004 Jun; 19(11):2991-6. PubMed ID: 15182306
[TBL] [Abstract][Full Text] [Related]
20. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
